Cargando…

A Nationwide Digital Multidisciplinary Intervention Aimed at Promoting Pneumococcal Vaccination in Immunocompromised Patients

Immunocompromised patients (IPs) are at high risk for infections, some of which are vaccine-preventable. The Israeli Ministry of Health recommends pneumococcal conjugate vaccine 13 (PCV13) and pneumococcal polysaccharide vaccine 23 (PPSV23) for IP, but vaccine coverage is suboptimal. We assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapiro Ben David, Shirley, Shamai-Lubovitz, Orna, Mourad, Vered, Goren, Iris, Cohen Iunger, Erica, Alcalay, Tamar, Irony, Angela, Greenfeld, Shira, Adler, Limor, Cahan, Amos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458143/ https://www.ncbi.nlm.nih.gov/pubmed/37631923 http://dx.doi.org/10.3390/vaccines11081355

Ejemplares similares

98. A nationwide intervention to improve pneumococcal vaccination rate among immunocompromised individuals
por: David, Shirley Shapiro Ben, et al.
Publicado: (2022)

Vaccination Coverage among Immunocompromised Patients in a Large Health Maintenance Organization: Findings from a Novel Computerized Registry
por: Shapiro Ben David, Shirley, et al.
Publicado: (2022)

350. Unnecessary viral blood tests reduction and costs saving by using an automated test request blocking system
por: Rahamim-Cohen, Daniella, et al.
Publicado: (2023)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
por: Froneman, Claire, et al.
Publicado: (2021)

Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study
por: Shapiro Ben David, Shirley, et al.
Publicado: (2022)

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
por: Mizrahi, Barak, et al.
Publicado: (2023)

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study
por: Ramirez, Julio, et al.
Publicado: (2021)

Multidisciplinary Management of Legionella Disease in Immunocompromised Patients
por: Kao, Andrew S, et al.
Publicado: (2021)

A Structured Educational Intervention Aims to Improve Pneumococcal Vaccination Practices in Primary Healthcare Centers
por: Alqifari, Saleh F, et al.
Publicado: (2023)

Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions
por: Liu, Junqing, et al.
Publicado: (2023)

Immunocompromised Children with Severe Adenoviral Respiratory Infection
por: Tylka, Joanna C., et al.
Publicado: (2016)

2205. Clinical Burden of Pneumococcal Disease in US Adults Aged 65 Years and Above with Chronic or Immunocompromising Conditions
por: Deb, Arijita, et al.
Publicado: (2019)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
por: Chilson, Erica, et al.
Publicado: (2020)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
por: Vietri, Jeffrey, et al.
Publicado: (2019)

Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
por: Bukan, Katrine, et al.
Publicado: (2023)

AN UNEXPECTED RECURRENCE: A CASE OF PNEUMOCYSTIS JIROVECI AND SARS-COV-2 IN AN IMMUNOCOMPROMISED PATIENT
por: PALACIOS, CARLOS, et al.
Publicado: (2022)

Pediatric Community- Acquired Bacteremia Before and After the Introduction of the Pneumococcal Conjugate Vaccine into the National Immunization Program in Israel
por: Berger, Yael, et al.
Publicado: (2017)

Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov
por: Cahan, Amos, et al.
Publicado: (2017)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Bennett, Nancy M., et al.
Publicado: (2013)

Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study
por: Zhang, Dongmu, et al.
Publicado: (2018)

Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time
por: Sprenger, Ralf, et al.
Publicado: (2022)

How to boost the boosters? A survey-experiment on the effectiveness of different policies aimed at enhancing acceptance of a “Seasonal” vaccination against COVID-19
por: Goren, Talia, et al.
Publicado: (2022)

Data-Driven Assessment of Adolescents’ Mental Health During the COVID-19 Pandemic
por: Bilu, Yonatan, et al.
Publicado: (2023)

Risk of major osteoporotic fractures among ultra-orthodox Jews
por: Jacobson Bensky, Merav, et al.
Publicado: (2022)

COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
por: Jakharia, Niyati, et al.
Publicado: (2022)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

A Learning Health Care System Using Computer-Aided Diagnosis
por: Cahan, Amos, et al.
Publicado: (2017)

A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
por: Schechner, Vered, et al.
Publicado: (2021)

Pneumococcal vaccination rates in immunocompromised patients—A cohort study based on claims data from more than 200,000 patients in Germany
por: Schmedt, Niklas, et al.
Publicado: (2019)

The Pandemic's impacts on patients without Covid-19 on multidisciplinary aspects in emergency medicine care
por: Ben-Haim, Gal, et al.
Publicado: (2021)

Attitudes of healthcare workers and members of the public toward the COVID-19 vaccine: A cross-sectional survey
por: Ramot, Shira, et al.
Publicado: (2022)

Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine
por: Ramot, Shira, et al.
Publicado: (2023)

Supporting healthcare workers in vaccination efforts
por: Ramot, Shira, et al.
Publicado: (2023)

Clinical Trials.Gov: A Topical Analyses
por: Anand, Vibha, et al.
Publicado: (2017)

Engineered Toxins “Zymoxins” Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain
por: Shapira, Assaf, et al.
Publicado: (2011)

Risk Stratification Model for Severe COVID-19 Disease: A Retrospective Cohort Study
por: Mizrahi Reuveni, Miri, et al.
Publicado: (2023)

Sporotrichosis In Immunocompromised Hosts
por: Queiroz-Telles, Flavio, et al.
Publicado: (2019)

Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012)

Vaccination of Immunocompromised Cats
por: Hartmann, Katrin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_os83tvbo0jl39m9u5i8vr00hpf